Toward a New Regulatory Framework for Clinical Research (Invite only)

-

While regulations and policies governing clinical research are vital to safeguarding clinical trial participants, they can also place undue burdens on researchers and slow trial recruitment. This private session will explore how streamlining regulations and oversight could accelerate clinical research by reducing unnecessary hurdles for researchers, trial sites, and participants. In this private session, attendees will examine a potential regulatory framework and explore how existing regulatory flexibilities can be better leveraged. 

    Moderator

    Image

    Kevin Bugin

    Associate Vice President, Global Regulatory Policy and Intelligence, Amgen

    Speakers

    Image

    Lora Black

    Vice President, Clinical Research, Sanford Health
    Image

    Ann Meeker-O'Connell

    Executive Director, Monitoring Excellence, Novartis

    Tracks